Cumberland Pharmaceuticals Inc. (CPIX)

Market Cap	15.31M
Revenue (ttm)	36.79M
Net Income (ttm)	-10.87M
Shares Out	14.04M
EPS (ttm)	-0.77
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,246
Open	1.140
Previous Close	1.110
Day's Range	1.090 - 1.140
52-Week Range	1.070 - 2.360
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About CPIX

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infect...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Aug 11, 2009
• Employees: 91
• Stock Exchange: NASDAQ
• Ticker Symbol: CPIX
• Website: https://www.cumberlandpharma.com

Financial Performance

In 2023, CPIX's revenue was $39.55 million, a decrease of -5.85% compared to the previous year's $42.01 million. Losses were -$6.28 million, 12.7% more than in 2022.